| __timestamp | AbbVie Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15534000000 | 175000 |
| Thursday, January 1, 2015 | 18359000000 | 382000 |
| Friday, January 1, 2016 | 19805000000 | 158333 |
| Sunday, January 1, 2017 | 21176000000 | 31407709 |
| Monday, January 1, 2018 | 25035000000 | 16142321 |
| Tuesday, January 1, 2019 | 25827000000 | 168795577 |
| Wednesday, January 1, 2020 | 30417000000 | 87992066 |
| Friday, January 1, 2021 | 38751000000 | 138287000 |
| Saturday, January 1, 2022 | 40640000000 | 232810000 |
| Sunday, January 1, 2023 | 33903000000 | 240735000 |
| Monday, January 1, 2024 | 39430000000 | 3551000 |
Infusing magic into the data realm
In the ever-evolving landscape of biopharmaceuticals, the financial trajectories of AbbVie Inc. and Arrowhead Pharmaceuticals, Inc. offer a fascinating study. From 2014 to 2023, AbbVie has consistently demonstrated robust growth, with its gross profit soaring by approximately 118%, peaking in 2022. This growth underscores AbbVie's strategic prowess in the pharmaceutical sector. In contrast, Arrowhead Pharmaceuticals, while smaller in scale, has shown remarkable resilience and potential. Despite starting with a modest gross profit in 2014, Arrowhead's figures have surged by over 1,300% by 2023, reflecting its innovative approach in RNA interference therapies. However, the data for 2024 remains incomplete, leaving room for speculation on future trends. This comparison not only highlights the diverse strategies of these companies but also the dynamic nature of the biopharma industry.
Gross Profit Analysis: Comparing AbbVie Inc. and Zoetis Inc.
Key Insights on Gross Profit: AbbVie Inc. vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Novartis AG or Arrowhead Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Ascendis Pharma A/S vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Grifols, S.A. vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? MorphoSys AG or Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: Vericel Corporation vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: Arrowhead Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Arrowhead Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Arrowhead Pharmaceuticals, Inc. vs Evotec SE: A Gross Profit Performance Breakdown